Mineros Announces Departure of Chief Financial Officer
Mineros S.A. (TSX:MSA, MINEROS:CB) (' Mineros ' or the ' Company ') announces the departure of Alan Wancier, its Chief Financial Officer, effective June 20, 2025.
David Londoño, President and Chief Executive Officer said, 'I want to express my most sincere gratitude for Mr. Wancier's years of hard work and commitment to Mineros, starting in the finance group at our Hemco Property in Nicaragua. His service and leadership to the Company during the past 11 years have been invaluable and he has made many contributions to the development and evolution of Mineros. We wish him every future success.'
Sergio Alejandro Chavarria Munera, Mineros' Director of Finance, has agreed to act and will be appointed as Interim Chief Financial Officer while a search is conducted for Mr. Wancier's replacement. Mr. Chavarria has held progressively more senior roles in finance with Mineros since 2018. Before joining Mineros, he was a Senior Audit Officer at Deloitte. Mr. Chavarria holds a Master of Business Administration from EAFIT University, and a degree in economics from the National University of Colombia.
ABOUT MINEROS S.A.
Mineros is a gold mining company headquartered in Medellin, Colombia. The Company has a diversified asset base, with relatively low-cost mines in Colombia and Nicaragua and a pipeline of development and exploration projects throughout the region.
The board of directors and management of Mineros have extensive experience in mining, corporate development, finance and sustainability. Mineros has a long track record of maximizing shareholder value and delivering solid annual dividends. For almost 50 years Mineros has operated with a focus on safety and sustainability at all its operations.
Mineros' common shares are listed on the Toronto Stock Exchange under the symbol 'MSA', and on the Colombia Stock Exchange under the symbol 'MINEROS'.
Election of Directors – Electoral Quotient System
The Company has been granted an exemption from the individual voting and majority voting requirements applicable to listed issuers under Toronto Stock Exchange policies, on grounds that compliance with such requirements would constitute a breach of Colombian laws and regulations which require the directors to be elected on the basis of a slate of nominees proposed for election pursuant to an electoral quotient system. For further information, please see the Company's most recent annual information form, available on the Company's website at https://www.mineros.com.co/ and from SEDAR+ at www.sedarplus.com.
FORWARD-LOOKING STATEMENTS
This news release contains 'forward-looking information' within the meaning of applicable Canadian securities laws. Forward-looking information includes statements that use forward-looking terminology such as 'may', 'could', 'would', 'will', 'should', 'intend', 'target', 'plan', 'expect', 'budget', 'estimate', 'forecast', 'schedule', 'anticipate', 'believe', 'continue', 'potential', 'view' or the negative or grammatical variation thereof or other variations thereof or comparable terminology. Such forward-looking information includes, without limitation, the expected departure timeline and transition for the Chief Financial Officer position, any other statement that may predict, forecast, indicate or imply future plans, intentions, levels of activity, results, performance or achievements.
Forward-looking information is based upon estimates and assumptions of management considering management's experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this news release. While the Company considers these assumptions to be reasonable, the assumptions are inherently subject to significant business, social, economic, political, regulatory, competitive and other risks and uncertainties, contingencies and other factors that could cause actual actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking information. Many assumptions are based on factors and events that are not within the control of the Company and there is no assurance they will prove to be correct.
For further information of these and other risk factors, please see the 'Risk Factors' section of the Company's annual information form dated March 25, 2024, available on SEDAR+ at www.sedarplus.com.
The Company cautions that the foregoing lists of important assumptions and factors are not exhaustive. Other events or circumstances could cause actual results to differ materially from those estimated or projected and expressed in, or implied by, the forward-looking information contained herein. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information.
Forward-looking information contained herein is made as of the date of this news release and the Company disclaims any obligation to update or revise any forward-looking information, whether as a result of new information, future events or results or otherwise, except as and to the extent required by applicable securities laws.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
9 hours ago
- Globe and Mail
Val-d'Or Mining Closes Private Placement Financing
Val-d'Or, Québec--(Newsfile Corp. - June 20, 2025) - Further to its news release of May 9, 2025, Val-d'Or Mining Corporation (TSXV: VZZ) (the "Company") is pleased to announce that it has completed a non-brokered private placement offering (the "Offering") for gross proceeds of $704,600. The Company issued 14,092,000 Units under the Offering at a per Unit price of $0.05, each Unit comprised of one common share in the capital of the Company and one non-transferable common share purchase warrant (a "Warrant") exercisable for the purchase of one common share of the Company at a per share price of $0.075 until June 20, 2027. Six insiders participated in the Offering for aggregate cash consideration to the Company of $251,600, which constitutes a Related Party Transaction under TSX Venture Exchange Policy 5.9. The Company availed itself of the exemptions contained in section 5.5(c) of Multilateral Instrument 61-101 ("MI 61-101") for an exemption from the formal valuation requirement and Section 5.7(1)(b) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the securities to be distributed in the transaction, and the consideration to be received by the Company for those securities, insofar as the transaction involves interested parties did not exceed $2,500,000. In connection with the Offering, the Company paid cash finder's fees in the amount of $7,200 and issued 144,000 finder's warrants exercisable at a price of $0.075 until June 20, 2027, to arm's length finders. An administration fee of $6,000 was paid by the Company to one of the subscribers under the Offering. The net proceeds raised from the Offering will be used for the advancement of the Company's projects and for general corporate purposes. All securities issued under the Offering, including common shares underlying the Warrants and finder's warrants, are subject to a hold period until October 21, 2025, in accordance with applicable securities legislation and the policies of the TSX Venture Exchange. About Val-d'Or Mining Corporation Val-d'Or Mining Corporation is a junior natural resource issuer involved in the process of acquiring and exploring its mineral property assets, most of which are situated in the Abitibi Greenstone Belt of NE Ontario and NW Québec. To complement its current property interests, the Company regularly evaluates new opportunities for staking and/or acquisitions. Outside of its principal regional focus in the Abitibi Greenstone Belt, the Company holds several other properties in Northern Québec (Nunavik) covering different geological environments and commodities (Ni-Cu-PGE's). The Company has expertise in the identification and generation of new projects, and in early-stage exploration. The mineral commodities of interest are broad, and range from gold, copper-zinc-silver, nickel-copper-PGE to industrial and energy minerals. After the initial value creation in the 100%-owned, or majority-owned properties, the Company seeks option/joint venture partners with the technical expertise and financial capacity to conduct more advanced exploration projects. For additional information, please contact: Glenn J. Mullan 2772 chemin Sullivan Val-d'Or, Québec J9P 0B9 Tel.: 819-824-2808, x 204 Email: Forward-Looking Statements: This news release contains certain statements that may be deemed "forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or realities may differ materially from those in forward looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by law, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.
Globe and Mail
15 hours ago
- Globe and Mail
The Smart Money Is Moving Toward AI Healthcare Tools That Actually Touch Patients
Issued on behalf of Avant Technologies Inc. VANCOUVER – News Commentary – AI is rapidly infiltrating every corner of the healthcare system, but so far, ambient scribes have taken the lead as the most visible breakthrough. As adoption broadens, experts are now evaluating which tools offer real ROI—and how quickly early adopters could benefit. Clinician workloads are already shrinking thanks to voice AI, while hospitals are deploying intelligent agents to streamline operations and boost care quality. For investors still hunting early-stage opportunities in this space, several publicly traded names are showing fresh momentum, including Avant Technologies, Inc. (OTCQB: AVAI), NVIDIA Corporation (NASDAQ: NVDA), Novo Nordisk A/S (NYSE: NVO), Alphabet, Inc. (NASDAQ: GOOG, GOOGL), and Microsoft Corporation (NASDAQ: MSFT). Private-market momentum is heating up fast, with venture capital pouring into AI-driven healthcare startups. In the first quarter alone, AI companies secured over half of all digital health funding—underscoring the sector's growing appeal. Notable rounds include $45 million for Ellipsis Health and $28 million for Autonomize AI, both focused on reshaping clinical decision-making. From early diagnostics to advanced drug discovery, the pace of innovation is picking up—and retail investors are starting to take notice. One example is the rollout of AI-powered screenings for diabetic retinopathy now underway across Costa Rica, Nicaragua, and Panama. Avant Technologies, Inc. (OTCQB: AVAI) and joint-venture partner Ainnova Tech have begun offering free Vision AI scans inside Grupo Dökka's Fischel and La Bomba pharmacy chains. The fast, non-invasive test detects early retinal changes—often before symptoms appear—and delivers secure results within minutes. By embedding the service in retail pharmacies and preparing for a parallel launch in Mexico, the partners are bringing care closer to patients while generating real-world data to support broader commercialization. "As we begin similar initiatives in Mexico, our goal is to close the patient care loop with timely treatment, connecting every step of the journey," said Vinicio Vargas, CEO of Ainnova Tech and board member of Ai-nova Acquisition Corp. "We are integrating pharma, retail, ophthalmologists, and our technology into a unified experience, all driven by one incentive, the well-being of the diabetic patient." The rollout also gives Avant a timely proof point as it moves to consolidate Vision AI under one roof. Earlier this month, the company signed a non-binding letter of intent to acquire 100% of Ainnova Tech —bringing leadership, data, and intellectual property together ahead of a scheduled FDA pre-submission meeting in July. Folding the joint venture into a single public entity would remove the current holding-company structure, streamlining everything from regulatory filings to revenue recognition. Management sees the unified cap table as a potential draw for both investors and strategic partners. While the legal teams work through due diligence, engineers are finalizing a low-cost, automated retinal camera built to work seamlessly with the Vision AI platform. Legacy fundus cameras can run into the tens of thousands and typically require skilled operators. Avant's prototype is fully automated, cloud-connected, and designed for a fraction of the cost. If performance holds up to internal testing, the system could enable large-scale diabetic screenings in clinics and low-resource settings—without the need for additional specialist staff. Vision AI is also expanding beyond diabetic eye disease. A patented dementia-risk module —pairing a five-minute blood test with AI pattern recognition—is now in validation, while cardiovascular-risk analytics are advancing through pilot studies across Latin America. Because every new use case plugs into the same software backbone, Avant looks more like a scalable platform than a single-product company. On the financial side, the planned merger would fold all outstanding Ainnova shares into Avant's public float, avoiding cash dilution and fully aligning the combined team's incentives. Management says any future fund-raising would be aimed at three priorities: completing the automated camera, widening pharmacy deployments, and supporting U.S. regulatory milestones. Taken together, the pharmacy roll-out, planned Ainnova acquisition, and imminent camera launch signal a turning point for Avant. What began as an AI incubator is fast becoming a full-stack diagnostics company, complete with proprietary hardware, an expanding library of predictive algorithms, and retail-level distribution partners. If execution matches vision, Vision AI could cut referral delays, open earlier treatment windows, and give resource-strained health systems specialist-grade insight at primary-care prices—turning headline-grabbing tech into tangible patient benefits. NVIDIA Corporation (NASDAQ: NVDA) and Novo Nordisk A/S (NYSE: NVO) are joining forces to advance drug discovery using AI models trained on the NVIDIA DGX Cloud platform. The partnership is supported by Denmark's DCAI supercomputing center and aims to improve early-stage research for identifying drug targets and molecules. 'AI is essential for every industry, and there's no other field that will benefit more from acceleration than drug discovery,' said Rory Kelleher, senior director of business development for life sciences at NVIDIA. 'Working with Novo Nordisk, we're advancing critical R&D applications with fundamental tools that can harness the full potential of generative and agentic AI to improve pharmaceutical development.' Novo Nordisk will adopt NVIDIA's BioNeMo platform to build customized generative AI tools using its proprietary biological data. 'By coupling NVIDIA's accelerated computing platform and expertise with Novo's deep expertise in life sciences research and development, we aim to build custom models that will aid our scientists in developing new medicines faster and more efficiently,' said Mishal Patel, senior vice president, AI and digital innovation at Novo Nordisk. 'Gefion will allow us to run experiments at an unprecedented scale.' DCAI views this collaboration as a model for how public supercomputing resources can unlock innovation in life sciences. For investors, the alliance highlights a rising trend of AI infrastructure enabling breakthroughs in biopharma. Alphabet, Inc. (NASDAQ: GOOG, GOOGL) subsidiary Google, through its DeepMind division, has introduced Med-Gemma, a new generative AI model optimized for healthcare developers building diagnostic and imaging apps. The tool aims to streamline early-stage development by offering pretrained models trained on expansive medical imaging datasets. Med-Gemma joins other Google health-focused initiatives like Med-PaLM 2 and AMIE, signaling a coordinated strategy toward AI-native clinical applications. The company continues to expand its AI footprint across healthcare with open-access tools designed to catalyze innovation at scale. Microsoft Corporation (NASDAQ: MSFT) is advancing healthcare AI innovation through strategic initiatives presented at HLTH Europe 2025, emphasizing breakthroughs in diagnostics and precision medicine via collaborations like its Mayo Clinic partnership. A central feature was Dragon Copilot, a generative AI tool designed to streamline documentation and enhance clinician-patient engagement across Europe. Microsoft also addressed growing global health disparities by promoting equitable, inclusive solutions rooted in responsible AI practices. These efforts reflect Microsoft's goal of enabling healthier outcomes for patients and providers worldwide. Source: CONTACT: cs@ (250) 999-4849 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of Media Corp. ('BAY') BAY has been not been paid a fee for Avant Technologies Inc. advertising and/or digital media, but the owner(s) of BAY also own Market IQ Media Group, Inc., which has been paid a fee from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of BAY own shares of Avant Technologies Inc. which were purchased in the open market. BAY and all of it's respective employees, owners and affiliates reserve the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by BAY has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
National Post
17 hours ago
- National Post
TomaGold Set to Launch Strategic Drilling Campaign on its Chibougamau Projects
Article content Planned 53-hole exploration drilling campaign targeting mainly the Berrigan, Radar, David, Dufault and Obalski properties Article content MONTREAL — TOMAGOLD CORPORATION (TSXV: LOT) (' TomaGold ' or the ' Company ') is pleased to announce the upcoming launch of its 2025 drilling campaign, which will focus primarily on the properties currently under option from SOQUEM and Chibougamau Independent Mines in the Chibougamau Mining Camp, as well as its wholly-owned Obalski Project (the ' Chibougamau Projects '). Article content David Grondin, CEO of TomaGold stated: Article content 'The Chibougamau Mining Camp has recently attracted significant exploration activity, underscoring the region's increasing potential for gold and copper discoveries. Since the beginning of the year, we have compiled project data, advanced preliminary work, identified high-priority targets, and prepared our properties to be drill-ready. Our 53-hole exploration program will focus on our key projects—Berrigan, Radar, David, Dufault, and Obalski—with the objective of uncovering new gold-copper mineralization on well-defined, strategically selected targets. We are eager to commence drilling and build on the momentum in this highly prospective region.' Article content Drill and Work Permits Secured Article content TomaGold has obtained all the necessary drilling and work permits, including the ATI ('Autorisation de Travaux à Impact') and forestry permits, to begin exploration activities across its Chibougamau Projects. Article content Drill Pad Setup and Mobilization Status Article content All access trails to the drill sites have been cleared and secured, and the drill setups are ready for immediate mobilization. A total of 53 drill targets have been identified and are fully permitted. While preparing the sites during the winter, the team also conducted limited and selective surface sampling in select areas. Analytical results from this sampling are currently pending. Article content Geophysical Survey Work on Obalski Article content A downhole resistivity/induced polarization (IP) logging survey was conducted in hole OBS-17-002, which intersected the newly interpreted NE-SW Zone on the Obalski Project. The objective was to determine the in-situ physical properties of this high-grade copper-gold zone to define the most effective geophysical method for the upcoming drilling campaign. The resistivity and chargeability contrasts measured between the host rocks and the NE-SW Zone are up to 10,000 times more conductive and 10 times more chargeable, respectively. To confirm these results, the geophysical properties of hole OBS-23-032 were also measured. This hole was interpreted to have intersected the same NE-SW Zone some 65 m further south. The results again confirmed similar conductive and chargeable contrasts of 25,000x and 10x, respectively. These very high contrasts suggest that electromagnetic (EM) and induced polarization (IP) methods could be successfully applied in this geological context of the Obalski project and possibly the Chibougamau Camp. Article content 3D Modelling and Structural Reinterpretation Article content TomaGold has completed approximately 95% of the geological reinterpretation and 3D modeling of the Obalski project. The updated model incorporates historical and recent data, providing a more comprehensive understanding of structural controls and mineralization trends. Final conclusions and visuals from the model will be presented shortly. Article content The Company has initiated a similar modelling and reinterpretation process across its other projects, leveraging the structural insights gained from the Obalski project reinterpretation. Article content TomaGold has outlined a series of geophysical surveys to be conducted across its Chibougamau Projects in 2025, pending crew availability and seasonal access. These surveys are designed to refine drill targeting and enhance geological modelling across key assets. Article content Summary of Planned Geophysical Work by Project: Article content Project Planned Geophysical Survey Obalski (100% TomaGold) IP survey along the D vein, covering the Wilson and South zones Radar (Under option from SOQUEM) Airborne magnetic survey (50 m line spacing), ground IP surveys on new targets, possible 3D ambient tomography David (Under option from SOQUEM) Downhole IP in historical and recent drill holes, pending casing verification Dufault (Under option from SOQUEM) NW–SE IP survey over the 055° vein corridor; NE–SW IP over the Bourbeau Sill outlet zone Berrigan (Under option from Chibougamau Independent Mines) 2D and 3D modelling under way; geophysical surveys anticipated in subsequent phases Article content These surveys will complement the current structural reinterpretation work and support future drilling campaigns across the portfolio. Article content The technical content of this press release has been reviewed and approved by Jean Lafleur, the Company's Vice President of Exploration and a qualified person under National Instrument 43-101. Article content About TomaGold Article content TomaGold Corporation (TSXV: LOT) is a Canadian mineral exploration company engaged in the acquisition, assessment, exploration and development of gold, copper, rare earth elements and lithium projects. Its primary goal is to consolidate the Chibougamau Mining Camp in northern Quebec. In addition to the agreements to acquire 13 properties in the camp, the Company holds interests in two gold properties in the vicinity of the camp: Obalski and Doda Lake. TomaGold also owns a 100% interest in a lithium property and in the Star Lake rare earth elements property, located in the James Bay region of Quebec, as well as a 24.5% interest in the Baird property, located near the Red Lake mining camp in Ontario through a joint venture with Evolution Mining Ltd. and New Gold Inc. Article content Cautionary Statement on Forward-Looking Information Article content This news release includes certain statements that may be deemed 'forward-looking statements'. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words 'expects', 'plans', 'anticipates', 'believes', 'intends', 'estimates', 'projects', 'potential' and similar expressions, or that events or conditions 'will', 'would', 'may', 'could' or 'should' occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include the potential results of exploration and drilling activities, market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates, opinions, or other factors should change. Article content Article content Article content Article content Article content Contacts
